12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·08/18/2025 17:06:03
Listen to the news
Gainers
- Propanc Biopharma (NASDAQ:PPCB) shares moved upwards by 110.5% to $6.04 during Monday's regular session. The market value of their outstanding shares is at $33.3 million.
- Soligenix (NASDAQ:SNGX) shares rose 72.29% to $4.79. The market value of their outstanding shares is at $9.0 million. As per the news, the Q2 earnings report came out 2 days ago.
- Aspire Biopharma Hldgs (NASDAQ:ASBP) stock rose 63.81% to $0.59. The market value of their outstanding shares is at $17.7 million. The company's, Q2 earnings came out 3 days ago.
- Wellgistics Health (NASDAQ:WGRX) shares moved upwards by 41.89% to $0.88. The company's market cap stands at $47.0 million.
- GoodRx Holdings (NASDAQ:GDRX) stock increased by 37.8% to $5.14. The market value of their outstanding shares is at $1.3 billion.
- Burning Rock Biotech (NASDAQ:BNR) stock rose 27.8% to $9.56. The market value of their outstanding shares is at $76.7 million.
Losers
- Matinas BioPharma Hldgs (AMEX:MTNB) shares declined by 26.7% to $1.73 during Monday's regular session. The market value of their outstanding shares is at $12.0 million.
- Atlantic International (NASDAQ:ATLN) stock decreased by 26.36% to $3.72. The market value of their outstanding shares is at $311.3 million. The company's, Q2 earnings came out 2 days ago.
- Vyome Holdings (NASDAQ:HIND) shares decreased by 26.01% to $10.36. The company's market cap stands at $369.1 million.
- Tonix Pharmaceuticals (NASDAQ:TNXP) shares fell 21.91% to $40.1. The company's market cap stands at $450.1 million.
- USBC (AMEX:USBC) shares fell 21.65% to $1.52. The market value of their outstanding shares is at $745.4 million.
- Enlivex Therapeutics (NASDAQ:ENLV) shares fell 19.79% to $1.46. The market value of their outstanding shares is at $38.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.